Problem Solver
Towia Libermann
Areas Towia Libermann is Knowledgeable in:
personalized medicine, translational research, oncology, autoimmune diseases, inflammation, prostate cancer, breast cancer, multiple myeloma, liver cancer, liver fibrosis, type 1 and 2 diabetes, genomics, proteomics, bioinformatics, systems biology, biomarkers, diagnostics, signal transduction, drug discovery, companion diagnostics, PCR, next generation sequencing
Techniques Towia Libermann Uses:
Genomics, proteomics, bioinformatics, systems biology, robotics, cutting edge technologies, PCR, ELISA, personalized medicine, translational research
Towia Libermann's Problem Solving Skills:
- diabetes
- renal cell cancer
- liver cancer
- multiple myeloma
- immunology
- breast cancer
- molecular biology
- biochemistry
- bioinformatics
- genomics
- proteomics
- systems biology
- biomarker discovery and validation
- oncology
- drug discovery
- Crohn's disease
- prostate cancer
Towia Libermann's Problem Solving Experience:
- I developed patented technologies to target transcription factors using small peptides and peptide mimetics.
- I developed various bioinformatics and systems biology software tools.
- I developed patented technologies to target transcription factors with small molecules using high throughput in silico screening.
- I developed biomarker signatures for predicting response to chemotherapy and overall survival in ovarian cancer patients and response to sunitinib in renal cell cancer.
- I was the first one to characterize the gene regulation of Interleukin 6 expression.
- I identified a new panel of biomarkers for myelodysplastic syndrome.
- I was the first one to identify gene amplifications and overexpression of growth factor receptors in cancer.
- I was the first one to isolate and characterize 7 of 27 members of the Ets transcription factor/oncogene family that have been now demonstrated to play key roles in chromosomal abnormalities in various types of cancer.
- I developed genomic and proteomic profiles for renal cell cancer, prostate cancer, liver fibrosis, hepatocellular cancer, Crohn's disease, celiac disease, and type 1 diabetes.
- I have identified novel combination therapies for various cancers.